RT Journal Article
SR Electronic
T1 RosENet: Improving binding affinity prediction by leveraging molecular mechanics energies with a 3D Convolutional Neural Network
JF bioRxiv
FD Cold Spring Harbor Laboratory
SP 2020.05.12.090191
DO 10.1101/2020.05.12.090191
A1 Hussein Hassan-Harrirou
A1 Ce Zhang
A1 Thomas Lemmin
YR 2020
UL http://biorxiv.org/content/early/2020/05/14/2020.05.12.090191.abstract
AB The worldwide increase and proliferation of drug resistant microbes, coupled with the lag in new drug development represents a major threat to human health. In order to reduce the time and cost for exploring the chemical search space, drug discovery increasingly relies on computational biology approaches. One key step in these approaches is the need for the rapid and accurate prediction of the binding affinity for potential leads.Here, we present RosENet (Rosetta Energy Neural Network), a three-dimensional (3D) Convolutional Neural Network (CNN), which combines voxelized molecular mechanics energies and molecular descriptors for predicting the absolute binding affinity of protein – ligand complexes. By leveraging the physico-chemical properties captured by the molecular force field, our model achieved a Root Mean Square Error (RMSE) of 1.26 on the PDBBind v2016 core set. We also explored some limitations and the robustness of the PDBBind dataset and our approach, on nearly 500 structures, including structures determined by Nuclear Magnetic Resonance and virtual screening experiments. Our study demonstrated that molecular mechanics energies can be voxelized and used to help improve the predictive power of the CNNs. In the future, our framework can be extended to features extracted from other biophysical and biochemical models, such as molecular dynamics simulations.Availability https://github.com/DS3Lab/RosENetCompeting Interest StatementThe authors have declared no competing interest.CNNconvolutional neural networkRMSEroot mean square errorRSpearman’s correlation coefficientNMRnuclear magnetic resonanceKIinhibition constantKDdissociation constantIC50half maximal inhibitory concentrationpKDbinding affinities.